Sea Mild Biotechnology , Ltd.'s operating income is $23M.
Get informed when a big investor buys or sells
+ FollowAs of Jun 30, 2026
Trailing 12 months ending Jun 30, 2026
As of the most recent data (June 2026), 7516.TWO shows a operating income of $23M. That compares with $12M in the prior-year period — up 92.2% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, 7516.TWO's operating income is now $23M (was $12M) — a 92.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Sea Mild Biotechnology , Ltd. is outperforming or lagging.
Tracking 7516.TWO's operating income over time shows whether Sea Mild Biotechnology , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $23M That compares with $12M in the prior-year period — up 92.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this operating income page, Stockcircle has Sea Mild Biotechnology , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $23M) with ownership activity and broader fundamentals.